Browse hierarchy: [Gastroenterology, Urology (GU)](/submissions/GU) → [Subpart F — Therapeutic Devices](/submissions/GU/subpart-f%E2%80%94therapeutic-devices) → [21 CFR 876.5025](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/876.5025) → PIA — Vibrator For Climax Control Of Premature Ejaculation

# PIA · Vibrator For Climax Control Of Premature Ejaculation

_Gastroenterology, Urology · 21 CFR 876.5025 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/PIA

## Overview

- **Product Code:** PIA
- **Device Name:** Vibrator For Climax Control Of Premature Ejaculation
- **Regulation:** [21 CFR 876.5025](/submissions/GU/subpart-f%E2%80%94therapeutic-devices/876.5025)
- **Device Class:** 2
- **Review Panel:** [Gastroenterology, Urology](/submissions/GU)

## Identification

A vibrator for climax control of premature ejaculation is used for males who suffer from premature ejaculation. It is designed to increase the time between arousal and ejaculation using the stimulating vibratory effects of the device on the penis.

## Classification Rationale

Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9. The special controls for this device are:

## Special Controls

In combination with the general controls of the Food Drug & Cosmetic Act, the Vibrator for Climax Control of Premature Ejaculation is subject to the following special controls:

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9. The special controls for this device are:(1) The labeling must include specific instructions regarding the proper placement and use of the device.
(2) The portions of the device that contact the patient must be demonstrated to be biocompatible.
(3) Appropriate analysis/testing must demonstrate electromagnetic compatibility safety, electrical safety, and thermal safety of the device.
(4) Mechanical safety testing must demonstrate that the device will withstand forces encountered during use.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN130047](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/PIA/DEN130047.md) | PROLONG | Ergon Medical , Ltd. | Mar 20, 2015 | DENG |

## Top Applicants

- Ergon Medical , Ltd. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/PIA](https://fda.innolitics.com/submissions/GU/subpart-f%E2%80%94therapeutic-devices/PIA)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com